Stem Cell Therapy for Limbal Stem Cell Deficiency
Running, not enrolling · Phase 1
Conditions studied: Limbal Stem-cell Deficiency
In brief
This phase I study will collect preliminary information on the activity and safety of cLSC. We will investigate the ability to manufacture and transplant cLSC onto the cornea successfully at the time of surgery (feasibility), and have cLSC begin to populate the ocular surface (efficacy) without serious adverse events (safety).
Key facts
- Study ID
- NCT03957954
- Run by
- University of California, Los Angeles
- People needed
- 20
- Starts
- 2020-09-30
- Expected to finish
- 2027-04-30
- Last updated by the study team
- 2026-02-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.